Literature DB >> 23839504

Cerebral ischemia and reperfusion increases the heterogeneity of local oxygen supply/consumption balance.

Harvey R Weiss1, Jeremy Grayson, Xia Liu, Sylviana Barsoum, Harsh Shah, Oak Z Chi.   

Abstract

BACKGROUND AND
PURPOSE: After cerebral vessel blockage, local blood flow and O2 consumption becomes lower and oxygen extraction increases. With reperfusion, blood flow is partially restored. We examined the effects of ischemia-reperfusion on the heterogeneity of local venous oxygen saturation in rats in order to determine the pattern of microregional O2 supply/consumption balance in reperfusion.
METHODS: The middle cerebral artery was blocked for 1 hour using the internal carotid approach in 1 group (n=9) and was then reperfused for 2 hours in another group (n=9) of isoflurane-anesthetized rats. Regional cerebral blood flow was determined using a C(14)-iodoantipyrine autoradiographic technique. Regional small vessel arterial and venous oxygen saturations were determined microspectrophotometrically.
RESULTS: After 1 hour of ischemia, local cerebral blood flow (92±10 versus 50±10 mL/min per 100 g) and O2 consumption (4.5±0.6 versus 2.7±0.5 mL O2/min per 100 g) decreased compared with the contralateral cortex. Oxygen extraction increased (4.7±0.2 versus 5.4±0.3 mL O2/100 mL) and the variation in small vein (20-60 μm) O2 saturation as determined by its coefficient of variation (=100×SD/mean) increased (5.5 versus 10.5). With 2 hours of reperfusion, the blood flow decrement was reduced and O2 consumption returned to the value in the contralateral cortex. Oxygen extraction remained elevated in the ischemic-reperfused area and the coefficient of variation of small vein O2 saturation increased further (17.3).
CONCLUSIONS: These data indicated continued reduction of O2 supply/consumption balance with reperfusion. They also demonstrated many small regions of low oxygenation within the reperfused cortical region.

Entities:  

Keywords:  cerebral O2 consumption; cerebral O2 supply/consumption balance; cerebral blood flow; ischemia-reperfusion

Mesh:

Substances:

Year:  2013        PMID: 23839504     DOI: 10.1161/STROKEAHA.113.001172

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

Review 1.  The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy.

Authors:  Stelian Adrian Ritiu; Alexandru Florin Rogobete; Dorel Sandesc; Ovidiu Horea Bedreag; Marius Papurica; Sonia Elena Popovici; Daiana Toma; Robert Iulian Ivascu; Raluca Velovan; Dragos Nicolae Garofil; Dan Corneci; Lavinia Melania Bratu; Elena Mihaela Pahontu; Adriana Pistol
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

2.  Effects of rapamycin on cerebral oxygen supply and consumption during reperfusion after cerebral ischemia.

Authors:  O Z Chi; S Barsoum; N M Vega-Cotto; E Jacinto; X Liu; S J Mellender; H R Weiss
Journal:  Neuroscience       Date:  2015-12-29       Impact factor: 3.590

Review 3.  Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-07       Impact factor: 3.619

4.  Amide proton transfer-weighted MRI can detect tissue acidosis and monitor recovery in a transient middle cerebral artery occlusion model compared with a permanent occlusion model in rats.

Authors:  Ji Eun Park; Seung Chai Jung; Ho Sung Kim; Ji-Yeon Suh; Jin Hee Baek; Chul-Woong Woo; Bumwoo Park; Dong-Cheol Woo
Journal:  Eur Radiol       Date:  2019-01-21       Impact factor: 5.315

5.  Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption.

Authors:  Oak Z Chi; Antonio Chiricolo; Xia Liu; Nikhil Patel; Estela Jacinto; Harvey R Weiss
Journal:  Neurosci Lett       Date:  2021-07-29       Impact factor: 3.197

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.